Royalty Pharma lets Elan takeover bid expire
Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.
10 hours ago
not rated yet |
0
not rated yet |
0
